AU2001229677A1 - Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses - Google Patents
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency virusesInfo
- Publication number
- AU2001229677A1 AU2001229677A1 AU2001229677A AU2967701A AU2001229677A1 AU 2001229677 A1 AU2001229677 A1 AU 2001229677A1 AU 2001229677 A AU2001229677 A AU 2001229677A AU 2967701 A AU2967701 A AU 2967701A AU 2001229677 A1 AU2001229677 A1 AU 2001229677A1
- Authority
- AU
- Australia
- Prior art keywords
- live
- immunodeficiency viruses
- viral vaccines
- recombinant rhabdoviruses
- rhabdoviruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 208000029462 Immunodeficiency disease Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000007813 immunodeficiency Effects 0.000 title 1
- 229960004854 viral vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20041—Use of virus, viral particle or viral elements as a vector
- C12N2760/20043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49426200A | 2000-01-28 | 2000-01-28 | |
US09494262 | 2000-01-28 | ||
PCT/US2001/001989 WO2001055330A2 (en) | 2000-01-28 | 2001-01-22 | Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001229677A1 true AU2001229677A1 (en) | 2001-08-07 |
Family
ID=23963758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001229677A Abandoned AU2001229677A1 (en) | 2000-01-28 | 2001-01-22 | Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1255849A2 (en) |
JP (1) | JP2003535577A (en) |
CN (1) | CN1416471A (en) |
AU (1) | AU2001229677A1 (en) |
CA (1) | CA2396709A1 (en) |
WO (1) | WO2001055330A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322119C (en) * | 2002-11-14 | 2007-06-20 | 中国科学院水生生物研究所 | Mandarin fish rhabdo virus toxic strain, its preparation method and application |
BRPI0411099A (en) | 2003-06-05 | 2006-07-18 | Wyeth Corp | immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus proteins antigens |
CN105441483B (en) * | 2005-10-14 | 2019-05-10 | 美国政府健康及人类服务部,疾病控制和预防中心 | Rabies virus compositions and methods |
CN101384278A (en) * | 2005-12-14 | 2009-03-11 | 乔治亚大学研究基金公司 | Rabies vaccine |
RU2660566C2 (en) | 2012-10-01 | 2018-07-06 | Томас Джефферсон Юниверсити | Immunization with a rabies virus vector expressing foreign protein antigen |
CN106802348A (en) * | 2016-12-30 | 2017-06-06 | 广东华南联合疫苗开发院有限公司 | Sf Rhabdovirus N proteins Double-antibody sandwich enzymelinked immunosorbent detection kit and method |
CN115960922A (en) * | 2021-10-09 | 2023-04-14 | 吴可行 | Design and application of self-replicating RNA molecules |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001634A (en) * | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
WO1996010400A1 (en) * | 1994-09-30 | 1996-04-11 | The Uab Research Foundation | Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
US5780448A (en) * | 1995-11-07 | 1998-07-14 | Ottawa Civic Hospital Loeb Research | DNA-based vaccination of fish |
-
2001
- 2001-01-22 CA CA002396709A patent/CA2396709A1/en not_active Abandoned
- 2001-01-22 JP JP2001561135A patent/JP2003535577A/en active Pending
- 2001-01-22 WO PCT/US2001/001989 patent/WO2001055330A2/en not_active Application Discontinuation
- 2001-01-22 CN CN01804229A patent/CN1416471A/en active Pending
- 2001-01-22 AU AU2001229677A patent/AU2001229677A1/en not_active Abandoned
- 2001-01-22 EP EP01946888A patent/EP1255849A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2003535577A (en) | 2003-12-02 |
WO2001055330A3 (en) | 2002-03-28 |
EP1255849A2 (en) | 2002-11-13 |
WO2001055330A2 (en) | 2001-08-02 |
CN1416471A (en) | 2003-05-07 |
CA2396709A1 (en) | 2001-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL362705A1 (en) | Split enveloped virus preparation for intranasal delivery | |
GB0021281D0 (en) | Software virus protection | |
AU2001240109A1 (en) | Dna vaccines against poxviruses | |
IL150961A0 (en) | Human immunodeficiency virus vaccine | |
IL158428A0 (en) | Vaccine composition comprising at least one hiv virus antigen | |
IL153879A0 (en) | Modified virus | |
AU2001238401A1 (en) | Cold-adapted equine influenza viruses | |
AU2003301850A1 (en) | Hiv vaccine | |
AU2001229677A1 (en) | Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses | |
AU2292600A (en) | Varicella-zoster virus vaccines | |
AU2001278337A1 (en) | Respiratory syncytial virus vaccine | |
GB0001475D0 (en) | Virus strains | |
AU2001278323A1 (en) | Modified sialic acid vaccines | |
GB0001476D0 (en) | Herpes virus strains | |
AUPR160400A0 (en) | Plant virus promoter | |
AU2002239462A1 (en) | Compositions for protection against bovine viral diseases | |
AU2002221760A1 (en) | Vaccine for treating allergy | |
AU4957800A (en) | Vaccine against isa virus | |
AU2002236065A1 (en) | Papillomavirus vaccines | |
AU2002314274A1 (en) | Vaccination against the feline immunodeficiency virus | |
AU2002350181A1 (en) | Compositions and methods for viral delivery | |
ZA200201446B (en) | Babesia canis vaccine. | |
GB0111442D0 (en) | Method for preparing recombinant virus | |
AU2001266534A1 (en) | Papillomavirus vaccine | |
AU2001251761A1 (en) | Equine protozoal myeloencephalitis vaccine |